At a time when more than half of male infertility cannot be explained by current methods, a new test developed by a LifeScience company is able to measure male fertility. The test Cap-Score Male Fertility Assay is based on research patented by the lab at the Institute for Animal Health and Cornell University's College of Veterinary Medicine and was recently the subject of a study that appeared in the Journal of Molecular Reproduction and Development.
"Out of all the tests commonly used to measure sperm, the Cap-Score is the only one that prospectively has been shown to indicate the probability of a man to generate a pregnancy," said professor of reproductive biology in the Department of Biomedical Sciences, director of a new Master of Public Health program, as well as company's co-founder and chief scientific officer. This marks a major improvement over semen analysis, the standard…
